Igües no pequeño pa problemes grandes: tratamientos moleculares pa les enfermedaes musculares y cardiovasculares
PDF (Asturianu) (Español (España))

Como citar

Menéndez Caravia, X. (2022). Igües no pequeño pa problemes grandes: tratamientos moleculares pa les enfermedaes musculares y cardiovasculares. Ciencies. Cartafueyos Asturianos De Ciencia Y Teunoloxía, 12, 62–73. Retrieved from https://reunido.uniovi.es/index.php/CCACT/article/view/19149
PDF (Asturianu) (Español (España))

Referencies bibliográfiques

Cui M, et al. Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease. Development. 2018; 145(24).

Bang ML, et al. Understanding the molecular basis of cardiomyopathy. Am J Physiol Heart Circ Physiol. 2022; 322(2): H181-H233.

Veeder JA, et al. Chemotherapy-associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies. Pharmacotherapy. 2021; 41(12): 1066-80.

McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol. 2021; 18(1): 22-36.

Morton SU, et al. Genomic frontiers in congenital heart disease. Nat Rev Cardiol. 2022; 19(1): 26-42.

Chemello F, et al. Correction of muscular dystrophies by CRISPR gene editing. J Clin Invest. 2020; 130(6): 2766-76.

Cannata A, et al. Gene Therapy for the Heart Lessons Learned and Future Perspectives. Circ Res. 2020; 126(10): 1394-414.

Kieserman JM, et al. Current Landscape of Heart Failure Gene Therapy. J Am Heart Assoc. 2019; 8(10): e012239.

von Appen A, et al. LEM2 phase separation promotes ESCRT-mediated nuclear envelope reformation. Nature. 2020; 582(7810): 115-8.

Vietri M, et al. Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation. Nat Cell Biol. 2020; 22(7): 856-67.

Abdelfatah N, et al. Characterization of a Unique Form of Arrhythmic Cardiomyopathy Caused by Recessive Mutation in LEMD2. JACC Basic Transl Sci. 2019 ;4(2): 204-21.

Caravia XM, et al. Loss of function of the nuclear envelope protein LEMD2 causes DNA damagedependent cardiomyopathy. J Clin Invest. 2022; In press.

Mojica FJ, Rodriguez-Valera F. The discovery of CRISPR in archaea and bacteria. FEBS J. 2016; 283(17): 3162-9.

Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPRCas9. Science. 2014; 346(6213): 1258096.

Ledford H, Callaway E. Pioneers of revolutionary CRISPR gene editing win chemistry Nobel. Nature. 2020; 586(7829): 346-7.

Liu N, Olson EN. CRISPR Modeling and Correction of Cardiovascular Disease. Circ Res. 2022; 130(12): 1827-50.

Khera R, et al. Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings. Circ Heart Fail. 2017; 10(11).

Sadek H, Olson EN. Toward the Goal of Human Heart Regeneration. Cell Stem Cell. 2020; 26(1): 7-16.

Garry GA, et al. Direct reprogramming as a route to cardiac repair. Semin Cell Dev Biol. 2022; 122 :3-13.